CYTOKINETICS INC.

- USD (-)

- 15 min delayed data - NASDAQ Stocks

Open:	-
Change:	-
Volume:	-

Low:	-
High:	-
High / Low range:	-

Type:	Stocks
Ticker:	CYTK
ISIN:

CYTOKINETICS INC. news, videos and press releases

For more news please use our advanced search feature.
CYTOKINETICS INC. - More news...

Lastest news CYTOKINETICS INC.

01/30/2025 - 17:22 Kuehn Law Encourages Investors of Cytokinetics, Inc. to Contact Law Firm
07/20/2021 - 13:31 Thinking about buying stock in Immunome, Aldeyra Therapeutics, New Oriental Education, ConforMIS, or Cytokinetics?
07/19/2021 - 12:30 Thinking about buying stock in Cytokinetics, Property Solutions Acquisition, Imara, ConforMIS, or Sesen Bio?
07/14/2020 - 13:31 Thinking about buying stock in INmune Bio, Cytokinetics, Workhorse Group, Norwegian Cruise Line, or Seanergy Maritime Holdings?
12/13/2019 - 22:49 Cytokinetics, Incorporated - CYTK Stock Chart Technical Analysis for 12-13-2019
11/19/2019 - 22:07 Cytokinetics, Inc - CYTK Stock Chart Technical Analysis for 11-19-19
02/15/2018 - 12:00 Cytokinetics, Incorporated to Host Earnings Call
11/21/2017 - 22:12 Cytokinetics, Inc - CYTK Stock Chart Technical Analysis for 11-21-17
10/26/2017 - 09:15 Cytokinetics, Incorporated to Host Earnings Call
08/02/2017 - 10:10 Investor Network: Cytokinetics, Incorporated to Host Earnings Call
02/12/2017 - 11:05 Cytokinetics
02/02/2017 - 12:30 Cytokinetics and Royalty Pharma Announce $100 Million Transaction for Omecamtiv Mecarbil
12/16/2016 - 21:30 Cytokinetics Added to Nasdaq Biotechnology Index
12/09/2016 - 12:30 Cytokinetics Announces New Data Presented at the International Symposium on ALS/MND
12/07/2016 - 12:30 Origent Data Sciences and Cytokinetics Present Analyses Demonstrating Baseline Data Predict Measures of Vital Capacity in Patients With ALS
12/02/2016 - 21:00 Cytokinetics Announces Presentations at the International Symposium on ALS/MND
12/01/2016 - 12:30 Cytokinetics Announces Start of GALACTIC-HF, a Phase 3 Clinical Trial of Omecamtiv Mecarbil
11/30/2016 - 23:30 The Lancet Publishes Results From COSMIC-HF Trial Showing Omecamtiv Mecarbil Significantly Improved Cardiac Function in Patients With Chronic Heart Failure
11/22/2016 - 21:00 Cytokinetics to Participate in Upcoming Investor Conferences
11/14/2016 - 21:00 Cytokinetics Announces Presentation of Additional Results From COSMIC-HF at the AHA Annual Scientific Meeting
11/07/2016 - 21:00 Cytokinetics Announces New Results From COSMIC-HF to be Presented at the American Heart Association Scientific Sessions 2016
11/07/2016 - 12:30 Cytokinetics Announces Publication Relating to Novel Smooth Muscle Myosin Inhibitor
10/27/2016 - 20:00 Cytokinetics, Inc. Reports Third Quarter 2016 Financial Results
10/18/2016 - 11:30 Cytokinetics Announces First Patient Enrolled in VIGOR-ALS, an Open-Label Extension Clinical Trial of Tirasemtiv
10/13/2016 - 20:00 Cytokinetics to Announce Third Quarter Results on October 27, 2016
09/29/2016 - 11:30 Cytokinetics Announces Early Termination of Hart-Scott-Rodino Waiting Period for Expanded Collaboration With Astellas